PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development

PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development

Proteolysis Targeting Chimera (PROTACs) are a brand-new concept of therapeutics that use the ubiquitin-proteasome system for selective degradation of disease-related proteins. Like other therapeutics, PROTACs function by recruiting a protein target and a ubiquitin ligase that leads to the degradati...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanaul Mustafa, Md Sabir Hussain Siddiquee
Format: Article
Language:English
Published: German Journal of Pharmaceuticals and Biomaterials 2025-01-01
Series:German Journal of Pharmaceuticals and Biomaterials
Subjects:
PROTAC
targeted protein degradation
RNA viral infections
prodrug
Oncology
Alzheimer’s disease
Online Access:https://www.gjpb.de/index.php/gjpb/article/view/154
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items